[VRDN] QoQ Quarter Result on 31-Mar-2017 [#Q1]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
11-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -25.31%
YoY- -153.08%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 1,192 1,631 718 462 756 889 874 22.91%
PBT -6,386 -5,834 -7,312 -6,980 -5,570 -1,839 -2,507 86.19%
Tax 77 113 102 30 -71 0 0 -
NP -6,386 -5,834 -7,312 -6,980 -5,570 -1,839 -2,507 86.19%
Tax Rate - - - - - - - -
Total Cost 7,578 7,465 8,030 7,442 6,326 2,728 3,381 71.01%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin -535.74 -357.69 -1,018.38 -1,510.82 -736.77 -206.86 -286.84 51.48%
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS -4.30 -4.06 -5.12 -9.06 -7.23 -2.56 -3.50 14.66%
EPS Diluted -4.30 -4.06 -5.12 -9.06 -7.23 -2.56 -3.50 14.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.